Freedman Benjamin S
Nephron. 2018;138(1):42-47. doi: 10.1159/000480370. Epub 2017 Oct 10.
The clinical need for organ replacement therapies has inspired the idea of growing human organs in animal hosts. The injection of human pluripotent stem cells into animal blastocysts provides a possible strategy to accomplish this goal. Subject of Review: A recent study [Wu et al. Cell 2017;168:473-486.e415] tests the feasibility of this approach by creating chimeric embryos between humans and large domestic animals, including pigs and cattle. The study further examines the potential of combining CRISPR-Cas9 gene editing with blastocyst complementation to grow fully foreign organs in chimeric hosts. Second Opinion: Here, we consider what this report and related studies reveal about the likelihood of human-animal chimeras reaching the clinic and translating into therapies. A careful look suggests hope for eventual success in this area but also underscores important challenges that will require dedicated effort to resolve.
器官替代疗法的临床需求激发了在动物宿主中培育人体器官的想法。将人类多能干细胞注入动物囊胚为实现这一目标提供了一种可能的策略。综述主题:最近一项研究[Wu等人,《细胞》2017年;168:473 - 486.e415]通过在人类与大型家畜(包括猪和牛)之间创建嵌合胚胎来测试这种方法的可行性。该研究进一步探讨了将CRISPR - Cas9基因编辑与囊胚互补相结合,以在嵌合宿主中培育完全异体器官的潜力。专家意见:在此,我们思考这份报告及相关研究揭示了人类 - 动物嵌合体进入临床并转化为治疗方法的可能性有多大。仔细研究表明这一领域最终取得成功是有希望的,但也凸显了一些重要挑战,需要付出专门努力来解决。